HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Current Assets (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Current Assets came in at $1.6 billion in Q2 2026, down 2.44% year-over-year from $1.6 billion in Q2 2025, and down 0.89% quarter-over-quarter from $1.6 billion in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Current Assets (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Current Assets for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets fell 2.44% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 2.44% decrease from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 2419.89% from the prior year.
  • Current Assets was $1.6 billion for Q2 2026 at HUTCHMED (China), down from $1.6 billion in the prior quarter.
  • Over five years, Current Assets peaked at $1.6 billion in Q2 2025 and troughed at -$73.9 million in Q4 2023.
  • A 5-year average of $952.5 million and a median of $1.0 billion in 2024 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets plunged 108.8% in 2023 and jumped 2419.89% in 2025, its largest moves.
  • Over 5 years, Current Assets stood at $839.9 million in 2022, then sank by 108.8% to -$73.9 million in 2023, then advanced by 8.63% to -$67.6 million in 2024, then jumped by 2419.89% to $1.6 billion in 2025, then declined by 0.89% to $1.6 billion in 2026.
  • The last three Current Assets figures came in at $1.6 billion (Q2 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn 4.74 Bn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 1.55 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Bn
Dec 31, 2025 1.57 Bn
Jun 30, 2025 1.59 Bn
Dec 31, 2024 -67.56 Mn
Jun 30, 2024 1.05 Bn
Dec 31, 2023 -73.94 Mn
Jun 30, 2023 1.09 Bn
Dec 31, 2022 839.89 Mn
Jun 30, 2022 1.02 Bn
Dec 31, 2021 1.21 Bn
Jun 30, 2021 1.09 Bn
Mar 31, 2021 496.23 Mn
Dec 31, 2020 530.74 Mn
Jun 30, 2020 374.73 Mn
Dec 31, 2019 317.02 Mn
Sep 30, 2019 277.08 Mn
Jun 30, 2019 309.50 Mn
Mar 31, 2019 349.99 Mn
Dec 31, 2018 370.54 Mn
Jun 30, 2018 394.68 Mn